Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb 16:3:1098294.
doi: 10.3389/fruro.2023.1098294. eCollection 2023.

Small fiber polyneuropathy: A new therapeutic target in patients with interstitial cystitis/bladder pain syndrome?

Wyatt Whitman  1 , Maxwell Sandberg  1 , Peyton Lee  2 , Stephen J Walker  1   2
Affiliations
Review

Small fiber polyneuropathy: A new therapeutic target in patients with interstitial cystitis/bladder pain syndrome?

Wyatt Whitman et al. Front Urol. .

Abstract

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a debilitating chronic disease that, based on the variable efficacy observed with most therapeutic options, is difficult to treat effectively. A more targeted patient selection process for current and emerging therapeutic options would likely help to improve outcomes. This narrative review explores small fiber polyneuropathy (SFPN) in IC/BPS as part of a larger widespread pain phenotype and as a potential therapeutic target. Because SFPN is becoming increasingly implicated in polysyndromic pain disorders (e.g., IC/BPS, chronic pelvic pain, and fibromyalgia) in which immune dysregulation is a suspected pathophysiologic etiology, continued consideration should be given to immunomodulatory therapies such as intravenous immunoglobulin (IVIg). Moreover, since the small fibers affected in SFPN continue to grow even as people age, targeted treatment may prevent further destruction and provide long-term benefits as the fibers are given time to repair. In addition to therapeutic potential, having a definitive SFPN diagnosis may provide psychological benefit in a patient population for which symptoms have historically been attributed to negative psychological factors. Finally, based on emerging data in this area, we propose consideration be given to include SFPN testing in the work-up of patients with IC/BPS that are refractory to treatments or have multiple comorbid pain syndromes since it may be an indicator of the need for alternative therapies. We believe that SFPN will play an increasingly larger role in the clinical evaluation and management of polysyndromic pain disorders, including IC/BPS.

Keywords: immunotherapy; interstitial cystitis/bladder pain syndrome; pain; small fiber polyneuropathy; therapeutics.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Schematic outlining the process for determination of SFPN status in IC/BPS patients and the corresponding treatment recommendations. (Created with BioRender.com).
See this image and copyright information in PMC

References

    1. Clemens JQ, Erickson DR, Varela NP, Lai HH. Diagnosis and treatment of interstitial Cystitis/Bladder pain syndrome. J Urol (2022) 208(1):34–42. doi: 10.1097/JU.0000000000002756 - DOI - PubMed
    1. Plair A, Evans RJ, Langefeld CD, Matthews CA, Badlani G, Walker SJ. Anesthetic bladder capacity is a clinical biomarker for interstitial Cystitis/Bladder pain syndrome subtypes. Urology (2021) 158. doi: 10.1016/j.urology.2021.07.009 - DOI - PMC - PubMed
    1. Colaco M, Koslov DS, Keys T, Evans R, Badlani G, Andersson K, et al. Correlation of gene expression with bladder capacity in interstitial cystitis/bladder pain syndrome. J Urol (2014) 192(4):1123–9. doi: 10.1016/j.juro.2014.05.047 - DOI - PubMed
    1. Schachar JS, Evans RJ, Parks GE, Zambon J, Badlani G, Walker SJ. Histological evidence supports low anesthetic bladder capacity as a marker of a bladder-centric disease subtype in interstitial cystitis/bladder pain syndrome. Int Urogynecol J (2019) 30(11):1863–70. doi: 10.1007/s00192-019-04038-0 - DOI - PMC - PubMed
    1. Overholt TL, Matthews CA, Evans RJ, et al. Small fiber polyneuropathy is associated with non-Bladder-Centric interstitial Cystitis/Bladder pain syndrome patients. Female Pelvic Med Reconstr Surg (2021) 27(9):581–5. doi: 10.1097/SPV.0000000000000972 - DOI - PMC - PubMed

LinkOut - more resources